SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001628280-23-033772
Filing Date
2023-10-04
Accepted
2023-10-04 08:09:43
Documents
9
Period of Report
2023-10-04

Document Format Files

Seq Description Document Type Size
1 PRE 14A a20231004pre-14a.htm PRE 14A 366473
2 computer.jpg GRAPHIC 3083
3 frtx_logoxcolor.jpg GRAPHIC 64155
4 ml.jpg GRAPHIC 3585
5 proxycard1a.jpg GRAPHIC 242848
6 proxycard2.jpg GRAPHIC 361695
7 proxycard3a.jpg GRAPHIC 133712
8 proxycard4a.jpg GRAPHIC 891590
9 tel.jpg GRAPHIC 3575
  Complete submission text file 0001628280-23-033772.txt   2709722
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-21088 | Film No.: 231306602
SIC: 2836 Biological Products, (No Diagnostic Substances)